Allegro Diagnostics, Inc. Obtains $4,000,000 Series A Financing

  • Feed Type
  • Date
    3/7/2008
  • Company Name
    Allegro Diagnostics, Inc.
  • Mailing Address
    650 Albany Street Boston, MA 02118
  • Company Description
    Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
  • Website
    http://www.allegrodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Dan Rippy, President and CEO of Allegro Diagnostics said, “The Series A financing will enable us to take our first product, based on intellectual property developed at the Boston University School of Medicine, into the clinic to provide earlier, more accurate diagnosis of suspected lung cancer for patients and their doctors.”
  • M&A Terms
  • Venture Investor
    Kodiak Venture Partners
  • Venture Investor
    Catalyst Health & Technology Partners

By posting a comment, you agree to our terms and conditions.